Literature DB >> 6611651

Effect of baclofen enantiomorphs on the spinal trigeminal nucleus and steric similarities of carbamazepine.

C F Terrence, M Sax, G H Fromm, C H Chang, C S Yoo.   

Abstract

The seemingly structurally different drugs, baclofen and carbamazepine, have a similar neurophysiologic effect on the cat spinal trigeminal nucleus and a similar clinical effect in the amelioration of trigeminal neuralgia pain. In this investigation, we report on the enhancement of segmental inhibition by carbamazepine and l-baclofen; d-baclofen produced no effect on segmental inhibition. Doses of l-baclofen one fifth its equivalent racemic dosage produced a much greater enhancement of segmental inhibition. d-Baclofen, when given prior to l-baclofen, blocked the effect of l-baclofen on segmental inhibition and the unconditioned response at previously effective doses. Pretreatment with d-baclofen also blocked the effect of subsequent carbamazepine on segmental inhibition, but had no effect on the unconditioned response. Crystallographic evaluation of carbamazepine and the enantiomorphs of baclofen revealed a surprisingly good fit of baclofen isomers to moieties of the carbamazepine molecule. The results suggest that the baclofen enantiomorphs and carbamazepine have a common mechanism of action in the cat spinal trigeminal nucleus, and that d-baclofen, though inactive, is capable of interfering with the effect of l-baclofen and to a lesser extent with carbamazepine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6611651     DOI: 10.1159/000137839

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  7 in total

1.  Effects of carbamazepine on cerebrospinal fluid somatostatin.

Authors:  D R Rubinow; R M Post; P W Gold; J C Ballenger; S Reichlin
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Blockade of gamma-aminobutyric acid-receptors of the B-subtype inhibits the dopamine-induced enhancement of the release of cholecystokinin-like immunoreactivity from slices of rat dorsal caudatoputamen.

Authors:  U Conzelmann; D K Meyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

Review 3.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

4.  Phosphinic acid derivatives as baclofen agonists and antagonists in the mammalian spinal cord: an in vivo study.

Authors:  G Lacey; D R Curtis
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

5.  Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain.

Authors:  J Sawynok; A Reid
Journal:  Neurochem Res       Date:  1986-05       Impact factor: 3.996

6.  Revisiting baclofen for the treatment of severe chronic tinnitus.

Authors:  Paul F Smith; Yiwen Zheng; Cynthia L Darlington
Journal:  Front Neurol       Date:  2012-03-09       Impact factor: 4.003

7.  Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments.

Authors:  Eder Gambeta; Juliana G Chichorro; Gerald W. Zamponi
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.